Priority Date: 01.04.13 (KR 20130035293)

Composition for combination therapy comprising an anti-C-met antibody and a FGFR inhibitor

  • Application ID: EP14162885
  • Status: The patent has been granted


Technology company logo small
Technology Company


Employment test 201 - 500 employees
Company dna grunecker kinkeldey stockmair and schwanhausser
operating since 1924
Headquarter in Munich and 2 offices
active in Legal Services


This EP application has the IPC combination A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) and C07 (ORGANIC CHEMISTRY). We found, that TransMIT GmbH, Kailuweit & Uhlemann, Lederer Keller Patentanwälte Partnerschaft mbB, Vossius & Partner Patentanwälte Rechtsanwälte mbB, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB and 228 others are specialized in this combination either. For a similar patent, they might be a good choice.


  • 01.04.2013 - Priority Date (KR 20130035293)
  • 08.10.2014 - Publication A2 (EP2786765)
  • 17.12.2014 - Publication A3 (EP2786765)
  • 03.10.2018 - Publication B1 (EP2786765)